Simplify Logo

Full-Time

Principal Scientist

LNP Development

Confirmed live in the last 24 hours

Beam Therapeutics

Beam Therapeutics

201-500 employees

Pioneering CRISPR base editing genetic medicines

Hardware
Biotechnology
Healthcare

Expert

Cambridge, MA, USA

Category
Biology Lab & Research
Biology & Biotech
Required Skills
Python
R
SQL
Requirements
  • PhD or MS in Pharmaceutical Sciences, Chemical engineering, Bioengineering or related field with of drug product and CMC development experience (PhD 8+ years or MS 18+ years)
  • Deep understanding of late stage product development activities
  • Product development experience especially in nucleic acids and drug delivery is preferred
  • Comprehensive knowledge and understanding of solubility, phase-separation, colloidal stability, electrostatic and hydrophobic interactions
  • Familiarity with ultrafiltration and aseptic unit operations for sterile drug product manufacture
  • Knowledge of statistical techniques and concepts
  • Experience using statistical computer languages (R, Python, SQL, etc.) to manipulate data and draw insights from large data sets
  • Excellent computational, written, and verbal communication skills
  • Strong organizational abilities
  • Ability to work with a diverse group of scientists and engineers
  • Ability to adapt to increasing scope and complexity of work brought on by growth/change
Responsibilities
  • Collaborate with scientists in application of statistics to Drug Product Development
  • Design and execute experiments for formulation and process development
  • Contribute to the Chemistry, Manufacturing and Controls (CMC) strategy
  • Lead technology transfer projects
  • Generate data for regulatory filings
  • Develop and maintain effective working relationships with other division groups

Beam Therapeutics is a cutting-edge biopharmaceutical company specializing in CRISPR base editing technology. This innovative approach enables precise, permanent modifications to single bases in DNA and RNA, paving the way for advanced genetic medicines tailored to cure serious diseases. The firm's commitment to precision and potential to offer life-long relief for patients make it an outstanding workplace for professionals passionate about leading transformative healthcare solutions.

Company Stage

IPO

Total Funding

$689M

Headquarters

Cambridge, Massachusetts

Founded

2017

Growth & Insights
Headcount

6 month growth

-1%

1 year growth

-11%

2 year growth

-6%